Haemonetics Corporation (HAE)
USD 78.77
(-4.02%)
USD 78.77
(-4.02%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 526.66 Million USD | 14.73% |
| 2023 | 459.06 Million USD | 5.83% |
| 2022 | 433.77 Million USD | 27.63% |
| 2021 | 339.87 Million USD | 2.82% |
| 2020 | 330.56 Million USD | -1.03% |
| 2019 | 333.99 Million USD | -6.12% |
| 2018 | 355.75 Million USD | 4.85% |
| 2017 | 339.28 Million USD | -8.19% |
| 2016 | 369.53 Million USD | -6.18% |
| 2015 | 393.87 Million USD | -6.45% |
| 2014 | 421.03 Million USD | 14.58% |
| 2013 | 367.44 Million USD | 30.27% |
| 2012 | 282.06 Million USD | 15.29% |
| 2011 | 244.66 Million USD | 1.58% |
| 2010 | 240.85 Million USD | 8.2% |
| 2009 | 222.6 Million USD | 18.76% |
| 2008 | 187.43 Million USD | 20.55% |
| 2007 | 155.48 Million USD | 27.95% |
| 2006 | 121.51 Million USD | -11.9% |
| 2005 | 137.93 Million USD | 9.26% |
| 2004 | 126.24 Million USD | 7.7% |
| 2003 | 117.21 Million USD | 8.15% |
| 2002 | 108.38 Million USD | -1.81% |
| 2001 | 110.38 Million USD | -9.96% |
| 2000 | 122.59 Million USD | -3.01% |
| 1999 | 126.4 Million USD | -1.02% |
| 1998 | 127.7 Million USD | 3.32% |
| 1997 | 123.6 Million USD | 8.99% |
| 1996 | 113.4 Million USD | 6.88% |
| 1995 | 106.1 Million USD | 3.61% |
| 1994 | 102.4 Million USD | 19.49% |
| 1993 | 85.7 Million USD | 26.03% |
| 1992 | 68 Million USD | 0.0% |
| 1991 | - USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 124.78 Million USD | 9.84% |
| 2024 Q4 | 120.43 Million USD | -8.68% |
| 2024 Q3 | 131.88 Million USD | 5.69% |
| 2024 FY | 468.39 Million USD | 2.03% |
| 2024 Q1 | 113.6 Million USD | -6.11% |
| 2023 Q1 | 111.49 Million USD | -4.32% |
| 2023 Q2 | 111.52 Million USD | 0.03% |
| 2023 Q3 | 115.42 Million USD | 3.5% |
| 2023 Q4 | 120.99 Million USD | 4.82% |
| 2023 FY | 459.06 Million USD | 5.83% |
| 2022 Q4 | 116.53 Million USD | 13.24% |
| 2022 FY | 433.77 Million USD | 27.63% |
| 2022 Q2 | 98.03 Million USD | -15.71% |
| 2022 Q3 | 102.91 Million USD | 4.98% |
| 2022 Q1 | 116.29 Million USD | 12.71% |
| 2021 Q3 | 80.94 Million USD | 3.17% |
| 2021 Q1 | 77.28 Million USD | -11.72% |
| 2021 Q2 | 78.46 Million USD | 1.52% |
| 2021 FY | 339.87 Million USD | 2.82% |
| 2021 Q4 | 103.18 Million USD | 27.47% |
| 2020 Q3 | 85.26 Million USD | 10.36% |
| 2020 Q2 | 77.26 Million USD | -4.01% |
| 2020 Q4 | 87.54 Million USD | 2.68% |
| 2020 FY | 330.56 Million USD | -1.03% |
| 2020 Q1 | 80.48 Million USD | -7.86% |
| 2019 Q2 | 85.83 Million USD | 10.11% |
| 2019 Q4 | 87.35 Million USD | 5.43% |
| 2019 Q3 | 82.85 Million USD | -3.47% |
| 2019 Q1 | 77.95 Million USD | -13.49% |
| 2019 FY | 333.99 Million USD | -6.12% |
| 2018 Q2 | 80.3 Million USD | 6.99% |
| 2018 FY | 355.75 Million USD | 4.85% |
| 2018 Q4 | 90.11 Million USD | -18.29% |
| 2018 Q1 | 75.05 Million USD | -8.92% |
| 2018 Q3 | 110.28 Million USD | 37.33% |
| 2017 Q1 | 98.93 Million USD | 4.39% |
| 2017 FY | 339.28 Million USD | -8.19% |
| 2017 Q2 | 79.45 Million USD | -19.69% |
| 2017 Q4 | 82.4 Million USD | 3.76% |
| 2017 Q3 | 79.41 Million USD | -0.05% |
| 2016 Q3 | 89.88 Million USD | 4.37% |
| 2016 FY | 369.53 Million USD | -6.18% |
| 2016 Q1 | 98.93 Million USD | 2.18% |
| 2016 Q4 | 94.77 Million USD | 5.44% |
| 2016 Q2 | 86.11 Million USD | -12.95% |
| 2015 Q1 | 107.94 Million USD | 5.01% |
| 2015 Q4 | 96.82 Million USD | 3.67% |
| 2015 Q3 | 93.4 Million USD | -2.41% |
| 2015 FY | 393.87 Million USD | -6.45% |
| 2015 Q2 | 95.7 Million USD | -11.34% |
| 2014 Q1 | 118.02 Million USD | 11.94% |
| 2014 FY | 421.03 Million USD | 14.58% |
| 2014 Q3 | 103.76 Million USD | 7.58% |
| 2014 Q2 | 96.45 Million USD | -18.27% |
| 2014 Q4 | 102.79 Million USD | -0.94% |
| 2013 Q3 | 97.36 Million USD | 5.99% |
| 2013 Q2 | 91.86 Million USD | 19.25% |
| 2013 Q1 | 77.03 Million USD | 4.59% |
| 2013 FY | 367.44 Million USD | 30.27% |
| 2013 Q4 | 105.43 Million USD | 8.28% |
| 2012 Q2 | 72.96 Million USD | 12.53% |
| 2012 Q3 | 70.6 Million USD | -3.23% |
| 2012 Q4 | 73.65 Million USD | 4.31% |
| 2012 Q1 | 64.84 Million USD | 14.33% |
| 2012 FY | 282.06 Million USD | 15.29% |
| 2011 Q3 | 64.93 Million USD | 6.89% |
| 2011 Q1 | 62.27 Million USD | -11.9% |
| 2011 Q2 | 60.74 Million USD | -2.46% |
| 2011 FY | 244.66 Million USD | 1.58% |
| 2011 Q4 | 56.71 Million USD | -12.66% |
| 2010 Q2 | 53.94 Million USD | -4.72% |
| 2010 Q1 | 56.61 Million USD | -11.56% |
| 2010 FY | 240.85 Million USD | 8.2% |
| 2010 Q4 | 70.68 Million USD | 18.57% |
| 2010 Q3 | 59.61 Million USD | 10.51% |
| 2009 Q3 | 53.8 Million USD | 5.33% |
| 2009 Q2 | 51.08 Million USD | -4.88% |
| 2009 Q4 | 64.01 Million USD | 18.98% |
| 2009 Q1 | 53.7 Million USD | 8.52% |
| 2009 FY | 222.6 Million USD | 18.76% |
| 2008 FY | 187.43 Million USD | 20.55% |
| 2008 Q4 | 49.48 Million USD | 5.38% |
| 2008 Q3 | 46.96 Million USD | 3.73% |
| 2008 Q1 | 45.71 Million USD | 39.04% |
| 2008 Q2 | 45.27 Million USD | -0.97% |
| 2007 Q1 | 42.33 Million USD | 404.59% |
| 2007 FY | 155.48 Million USD | 27.95% |
| 2007 Q4 | 32.87 Million USD | -16.58% |
| 2007 Q3 | 39.41 Million USD | -3.54% |
| 2007 Q2 | 40.86 Million USD | -3.47% |
| 2006 Q2 | 36.38 Million USD | 0.99% |
| 2006 Q1 | 36.02 Million USD | -4.37% |
| 2006 FY | 121.51 Million USD | -11.9% |
| 2006 Q4 | 8.38 Million USD | -79.39% |
| 2006 Q3 | 40.71 Million USD | 11.89% |
| 2005 Q2 | 31.63 Million USD | -1.56% |
| 2005 FY | 137.93 Million USD | 9.26% |
| 2005 Q1 | 32.13 Million USD | -3.64% |
| 2005 Q3 | 36.48 Million USD | 15.31% |
| 2005 Q4 | 37.67 Million USD | 3.28% |
| 2004 FY | 126.24 Million USD | 7.7% |
| 2004 Q2 | 32.47 Million USD | 3.42% |
| 2004 Q4 | 33.35 Million USD | 14.94% |
| 2004 Q1 | 31.4 Million USD | 4.39% |
| 2004 Q3 | 29.01 Million USD | -10.65% |
| 2003 Q4 | 30.07 Million USD | 3.3% |
| 2003 FY | 117.21 Million USD | 8.15% |
| 2003 Q3 | 29.11 Million USD | 0.19% |
| 2003 Q2 | 29.06 Million USD | 0.38% |
| 2003 Q1 | 28.95 Million USD | 77.3% |
| 2002 FY | 108.38 Million USD | -1.81% |
| 2002 Q2 | 26.84 Million USD | 181.65% |
| 2002 Q1 | 9.53 Million USD | -33.01% |
| 2002 Q3 | 38.42 Million USD | 43.14% |
| 2002 Q4 | 16.33 Million USD | -57.5% |
| 2001 FY | 110.38 Million USD | -9.96% |
| 2001 Q1 | 31.11 Million USD | 11.17% |
| 2001 Q2 | 30.97 Million USD | -0.44% |
| 2001 Q3 | 34.06 Million USD | 9.96% |
| 2001 Q4 | 14.22 Million USD | -58.23% |
| 2000 Q3 | 29.7 Million USD | -10.27% |
| 2000 FY | 122.59 Million USD | -3.01% |
| 2000 Q4 | 27.99 Million USD | -5.75% |
| 2000 Q1 | 31.7 Million USD | 11.23% |
| 2000 Q2 | 33.1 Million USD | 4.42% |
| 1999 Q1 | 35.5 Million USD | -8.74% |
| 1999 FY | 126.4 Million USD | -1.02% |
| 1999 Q4 | 28.5 Million USD | -8.36% |
| 1999 Q3 | 31.1 Million USD | -0.64% |
| 1999 Q2 | 31.3 Million USD | -11.83% |
| 1998 Q4 | 38.9 Million USD | 78.44% |
| 1998 FY | 127.7 Million USD | 3.32% |
| 1998 Q1 | 32.8 Million USD | 7.89% |
| 1998 Q2 | 34.1 Million USD | 3.96% |
| 1998 Q3 | 21.8 Million USD | -36.07% |
| 1997 Q1 | 30.7 Million USD | 14.13% |
| 1997 Q4 | 30.4 Million USD | -4.4% |
| 1997 Q3 | 31.8 Million USD | 3.58% |
| 1997 Q2 | 30.7 Million USD | 0.0% |
| 1997 FY | 123.6 Million USD | 8.99% |
| 1996 Q2 | 29 Million USD | 3.57% |
| 1996 Q1 | 28 Million USD | 6.87% |
| 1996 Q3 | 29.5 Million USD | 1.72% |
| 1996 FY | 113.4 Million USD | 6.88% |
| 1996 Q4 | 26.9 Million USD | -8.81% |
| 1995 Q4 | 26.2 Million USD | -1.87% |
| 1995 Q1 | 26.7 Million USD | 6.8% |
| 1995 Q2 | 26.5 Million USD | -0.75% |
| 1995 Q3 | 26.7 Million USD | 0.75% |
| 1995 FY | 106.1 Million USD | 3.61% |
| 1994 Q2 | 26.7 Million USD | 8.1% |
| 1994 Q1 | 24.7 Million USD | 10.27% |
| 1994 FY | 102.4 Million USD | 19.49% |
| 1994 Q4 | 25 Million USD | -3.85% |
| 1994 Q3 | 26 Million USD | -2.62% |
| 1993 Q3 | 22.6 Million USD | 8.13% |
| 1993 Q4 | 22.4 Million USD | -0.88% |
| 1993 FY | 85.7 Million USD | 26.03% |
| 1993 Q1 | 19.7 Million USD | 8.24% |
| 1993 Q2 | 20.9 Million USD | 6.09% |
| 1992 Q3 | 18 Million USD | 9.76% |
| 1992 Q4 | 18.2 Million USD | 1.11% |
| 1992 Q2 | 16.4 Million USD | 6.49% |
| 1992 FY | 68 Million USD | 0.0% |
| 1992 Q1 | 15.4 Million USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alcon Inc. | 4.2 Billion USD | 87.484% |
| AptarGroup, Inc. | 814.37 Million USD | 35.329% |
| Baxter International Inc. | 5.27 Billion USD | 90.01% |
| Becton, Dickinson and Company | 6.04 Billion USD | 91.29% |
| Bausch + Lomb Corporation | 2.37 Billion USD | 77.815% |
| Envista Holdings Corp | 1.15 Billion USD | 54.231% |
| ResMed Inc. | 1.36 Billion USD | 61.512% |
| Teleflex Incorporated | 1.08 Billion USD | 51.424% |
| Warby Parker Inc. | 437.22 Million USD | -20.458% |
| West Pharmaceutical Services, Inc. | 454 Million USD | -16.006% |